EP Patent

EP0552612A3 — Methods for determining and isolating compounds which bind directly to nucleosolic proteins

Assigned to F Hoffmann La Roche AG · Expires 1993-10-20 · 33y expired

What this patent protects

Patent listed against Azelex.

Drugs covered by this patent

Patent Metadata

Patent number
EP0552612A3
Jurisdiction
EP
Classification
—
Expires
1993-10-20
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.